Companies: 10,795·Total market cap: $144.5T
OncoVista Innovative Therapies, Inc.

OncoVista Innovative Therapies, Inc.

OVITOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2356
P/E Ratio—
52W High$0.0004
52W Low$0.0001
EarningsFinancialsRevenue

OncoVista Innovative Therapies, Inc. (OVIT) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

OVIT · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
No earnings history available.
No analyst estimates available for OVIT.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: OVIT ends December

OncoVista Innovative Therapies, Inc. (OVIT) reports earnings quarterly as a OTC-listed Biotechnology company. The next OVIT earnings date is expected around September 1, 2026.

Each quarter, investors track OVIT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OVIT revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OVIT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

OVIT earnings · 3 questions

OncoVista Innovative Therapies, Inc.'s next earnings report is expected around September 1, 2026. OVIT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OVIT historically reports after market close (AMC).

OVIT earnings datewhen is OVIT earningsOVIT next earnings datewhen does OVIT report earningsOVIT earnings calendar

▸ Source: FMP · OncoVista Innovative Therapies, Inc. SEC filings · US GAAP · OncoVista Innovative Therapies, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026